Detalhe da pesquisa
1.
Comparative assessment of immunogenicity of recombinant insulin Aspart from BioGenomics and its originator NovoRapid® in adult patients with type 2 diabetes mellitus.
J Endocrinol Invest
; 2023 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147290